Published Apr 1, 2026, 2:01 PM ET · Updated 7 months ago · 1 source
Novo Digs in to Protect Its No. 1 Spot in Obesity Pill Market
bloomberg
·
Original Report
INFERY
Earlier this year, Novo Nordisk A/S pulled off the best obesity-drug launch ever with its Wegovy pill. Now it’s focused on building on more than 600,000 prescriptions as Eli Lilly & Co. threatens to siphon patients away with a new pill of its own.